Search Browse Earnings

TG THERAPEUTICS, INC. — SlamSEC

TG THERAPEUTICS, INC.

Nasdaq:TGTX

Pharmaceutical Preparations·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$233.7M

+8290.0% YoY

FY 2025

Adj. EBITDA

$20.8M

8.9% margin

FY 2025

Net Income

$12.7M

5.4% margin

FY 2025

EPS (Diluted)

$0.09

FY 2025

Stock Price

$27.96

+3.8%

2026-03-13

52W Range

$25.28 – $46.48

P/E Ratio

310.7x

Market Cap

$4.5B

Cash

$92.9M

FY 2025

Total Debt

$244.6M

FY 2025

Net Debt

$151.7M

FY 2025

Enterprise Value

$4.6B

Debt / EBITDA

7.3x

FY 2025

EV / EBITDA

221.5x

Employees

—

CEO

Weiss Michael S

CFO

Power Sean A